11,274 results match your criteria: "Universite de Bordeaux[Affiliation]"
J Med Virol
October 2024
Université Paris Cité, Inserm IAME UMR 1137, Paris, F-75018, France.
Biol Psychiatry
October 2024
Fondation Fondamental, Créteil, France; Centre Hospitalier Universitaire de Montpellier, Hôpital Lapeyronie, Psychiatric Emergency and Post Emergency Department, Pole Urgence, Montpellier, France; L'Institut de Génomique Fonctionnelle, Université de Montpellier, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Montpellier, France. Electronic address:
Anal Chem
October 2024
Arts et Métiers Institute of Technology, CNRS, Université de Bordeaux, Bordeaux INP, Institut de Mécanique et d'Ingénierie (I2M), Bâtiment A11, 351 Cours de la Libération, 33405 Talence, France.
With the development of microtechnologies for energy conversion and storage, mass transfer and micromolar concentration variations need to be measured at the microscale. These advances need to be accompanied by novel imaging techniques with the capability of achieving high spatial resolution while detecting very small signal variations (less than 0.1%).
View Article and Find Full Text PDFAlzheimers Res Ther
October 2024
Univ. Bordeaux, Bordeaux Population Health, UMR1219, Inserm, Bordeaux, France.
Thorax
October 2024
Université de Bordeaux, INSERM, BPH, team AHeaD, U1219, Bordeaux, France.
Phys Rev Lett
September 2024
Department of Physics, University of Jyväskylä, Accelerator Laboratory, P.O. Box 35, FI-40014, Jyväskylä, Finland.
Comput Struct Biotechnol J
December 2024
Université Paris-Saclay, CEA, Cross-Cutting Program on Materials and Processes Skills, Gif-sur-Yvette 91191, France.
The quest to develop efficient, sustainable materials from non-critical, non-toxic resources is one of today's most formidable challenges in the current context of energy, transport, digital or healthcare transitions. In response, France launched the pioneering Priority Equipment and Research Program (PEPR) DIADEM in 2022. This innovative initiative, focused on DIscovery Acceleration for the Deployment of Emerging Materials (DIADEM), leverages Artificial Intelligence (AI) to accelerate the innovation chain from conception to realization, revolutionizing Materials Science sustainably.
View Article and Find Full Text PDFFront Genet
September 2024
Laboratoire de Biochimie, Pôle de Biologie et Pathologie, CHU de Bordeaux, Bordeaux, France.
Joint Bone Spine
December 2024
Université de Montpellier, Montpellier, France; Service de rhumatologie, CHU de Montpellier, CHU Lapeyronie, Montpellier, France; Inserm U1046, CNRS UMR 9214, University of Montpellier, Physiology and Experimental Medicine of the Heart and Muscles (PhyMedExp), Montpellier, France.
Lancet Healthy Longev
November 2024
Université de Bordeaux, INSERM, Institut Bergonié, CHU Bordeaux, CIC1401-EC, Euclid/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.
Nano Lett
October 2024
Université de Bordeaux - CNRS - CEA, CELIA, UMR5107, F33405 Talence, France.
Eur Radiol Exp
October 2024
Institut des Sciences Moléculaires, UMR5255, Université de Bordeaux, Talence, France.
Background: Longitudinal T1 relaxation time is a key imaging biomarker. In addition, T1 values are modulated by the administration of T1 contrast agents used in patients with tumors and metastases. However, in clinical practice, dedicated T1 mapping sequences are often not included in brain MRI protocols.
View Article and Find Full Text PDFPhys Chem Chem Phys
October 2024
CNRS, Université de Bordeaux, ISM, UMR 5255, F-33400 Talence, France.
Quantum benchmark calculations of the H + HOD abstraction reaction [B. Zhao , , 2018, , 17029-17037] provide an opportunity to test approximate methods, such as quasi-classical trajectories (QCTs) with Gaussian binning. However, the large mode-specific enhancements of this reaction lead to special challenges and unphysical QCT cross-section artifacts.
View Article and Find Full Text PDFGeriatr Psychol Neuropsychiatr Vieil
October 2024
CHU de Grenoble-Alpes, Président du Collège National des Enseignants de Gériatrie, France.
medRxiv
August 2024
Brain & Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia.
Am J Transplant
October 2024
Université de Bordeaux, CNRS, ImmunoConcEpT UMR_5164, INSERM ERL U1303, Equipe Labellisée par la Ligue Nationale Contre le Cancer, Bordeaux, France; Département de Néphrologie, Transplantation, Dialyse et Aphérèse, Hôpital Pellegrin, Bordeaux, France. Electronic address:
Belatacept, a fusion protein combining cytotoxic T-lymphocyte antigen-4 (CTLA-4) and the Fc region of human IgG1, is increasingly used as a calcineurin inhibitor-sparing regimen in patients with chronic graft dysfunction. Older kidney transplant recipients, particularly from expanded criteria donors, may be switched to belatacept due to poor renal recovery. However, late-onset cytomegalovirus (CMV) reactivation is increasingly reported with this treatment, especially in older patients with graft dysfunction.
View Article and Find Full Text PDFEncephale
October 2024
Richard L. Roudbush VA Medical Center, Indianapolis, IN, États-Unis; Indiana University School of Medicine, Indianapolis, IN, États-Unis.
Objectives: To demonstrate the effects of a metacognitive reflection and insight therapy (MERIT) in people suffering from psychiatric disorders.
Method: A systematic review was carried out on PubMed, PsychInfo, Psycharticles and Psychological and Behavioral Science Collection from 1980 to 2024.
Results: The review included five randomized controlled studies, four observational group studies and 22 case studies with quantitative measures.
HLA
October 2024
CHU de Lille, Institut d'Immunologie-HLA, Lille, France.
HLA-C*07:01:126 differs from HLA-C*07:01:01:01 by one nucleotide substitution in codon 328 in exon 7.
View Article and Find Full Text PDFEMBO J
December 2024
Umeå Plant Science Centre, Department of Forest Genetics and Plant Physiology, Swedish University of Agricultural Sciences, SE-901 87, Umeå, Sweden.
The control of cell-cell communication via plasmodesmata (PD) plays a key role in plant development. In tree buds, low-temperature conditions (LT) induce a switch in plasmodesmata from a closed to an open state, which restores cell-to-cell communication in the shoot apex and releases dormancy. Using genetic and cell-biological approaches, we have identified a previously uncharacterized transcription factor, Low-temperature-Induced MADS-box 1 (LIM1), as an LT-induced, direct upstream activator of the gibberellic acid (GA) pathway.
View Article and Find Full Text PDFSci Total Environ
December 2024
French Biodiversity Agency, Direction of Research & Scientific Support, 94300 Vincennes, France.
Despite their intensive use and their impact on ecosystems, biocides and surfactants are still poorly regulated and poorly monitored at large scale. In the frame of the revision of the national regulatory surveillance plan of surface waters, France planned in 2018 a monitoring campaign at national scale focused on these two types of substances of very emerging concern. Forty-nine contaminants (32 biocides and 17 surfactants) were investigated in surface water and sediment samples from 91 sampling sites, and in effluent and sludge samples of 7 wastewater treatment plants (WWTP), in mainland France and overseas regions.
View Article and Find Full Text PDFJ Med Genet
November 2024
Cancer Genetics Unit, Institut Bergonié, Bordeaux, Aquitaine, France.
J Chromatogr A
November 2024
Université de Bordeaux, INSERM U1212, UMR CNRS 5320, F-33076 Bordeaux, France.
Three-dimensional (3D) cancer models, such as multicellular tumor spheroids (MCTS), are biological supports used for research in oncology, drug development and nanotoxicity assays. However, due to various analytical and biological challenges, the main recurring problem faced when developing this type of 3D model is the lack of reproducibility. When using a 3D support to assess the effect of biologics, small molecules or nanoparticles, it is essential that the support remains constant over time and multiples productions.
View Article and Find Full Text PDFNeurotherapeutics
September 2024
TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.
A breadth of preclinical studies now support the rationale of pluripotent stem cell-derived cell replacement therapies to alleviate motor symptoms in Parkinsonian patients. Replacement of the primary dysfunctional cell population in the disease, i.e.
View Article and Find Full Text PDFHeartRhythm Case Rep
September 2024
Hôpital Cardiologique du Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, L'Institut de RYthmologie et modélisation Cardiaque (LIRYC), Université de Bordeaux, Bordeaux, France.
Biomacromolecules
October 2024
Université de Bordeaux, CNRS, Bordeaux INP, Laboratoire de chimie des polymères organiques (LCPO), UMR 5629, F-33600 Pessac, France.